Governance Roche Holding AG

ROG

CH0012032048

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 19:31:30 06/03/2026 +03			5-day change	1st Jan Change
341.20 ^CHF	-2.93%		-7.03%	+3.96%

03-07	Roche chairman still expects diagnostics hit from US tariffs	RE
03-06	Swiss Market Index Ends Week Downbeat; SFS Group Gains	MT

Executive Committee: Roche Holding AG

Manager

Positions heldSince

Thomas Schinecker

51 year

Chief Executive Officer

15/03/2023

Alan Hippe

59 year

Director of Finance/CFO

06/06/2011

Levi Garraway

58 year

Chief Tech/Sci/R&D Officer

01/01/2023

Pascale Schmidt

53 year

Compliance Officer

01/01/2020

Claudia Boeckstiegel

62 year

General Counsel

01/04/2020

Cristina Wilbur

59 year

Human Resources Officer

Bruno Eschli

Investor Relations Contact

01/08/2014

Per-Olof Attinger

66 year

Corporate Secretary

Wafaa Mamilli

59 year

Chief Tech/Sci/R&D Officer

10/02/2025

Composition of the Board of Directors: Roche Holding AG

Director

CommitteesSince

Severin Schwan

59 year

Chairman

15/03/2023

André Hoffmann

67 year

Governance Committee	01/01/1996
Nominating Committee	01/01/1996
Compensation Committee Chair	01/01/1996
Compensation Committee	01/01/1996
Governance Committee Chair	01/01/1996

Claudia Dyckerhoff

59 year

Audit Committee	01/03/2016
Governance Committee	01/03/2016
Compensation Committee	21/04/2016

Anita Hauser

57 year

Compensation Committee	14/03/2017
Nominating Committee	14/03/2017

Joerg Duschmale

42 year

Audit Committee	17/03/2020
Compensation Committee Chair	17/03/2020

Ulf Mark Schneider

61 year

Audit Committee	01/03/2023
Governance Committee	01/10/2014

Jemilah Mahmood

67 year

Governance Committee

01/03/2022

Akiko Iwasaki

56 year

Governance Committee

01/03/2023

Patrick Frost

58 year

Audit Committee Chair

17/03/2020

Richard P. Lifton

73 year

Director/Board Member	03/03/2015
Independent Dir/Board Member	03/03/2015

Latest Appointments: Roche Holding AG

02-27	Keros Therapeutics, Inc. Announces Board Changes, Effective March 9, 2026	CI
02-26	CEO of World Economic Forum quits after Epstein ties come to light	RE
02-26	CEO of World Economic Forum quits after Epstein ties come to light	RE
02-24	Adocia SA Announces Board Changes	CI
02-23	Zura Bio Limited Announces Board Changes, Effective February 21, 2026	CI
02-17	Roche appoints Mark Dawson as new head of Roche pharma research and early development	RE
02-17	Roche Announces the Appointment of Mark Dawson as New Head of Roche Pharma Research and Early Development and Member of the Enlarged Corporate Executive Committee, Effective 1 May 2026	CI

More news

Former Officers and Directors: Roche Holding AG

Insider

Positions held

SinceUntil

Christoph Franz

Chairman	01/03/2014	15/03/2023
Independent Dir/Board Member	01/03/2014	15/03/2023

Nicolas Dunant

Public Communications Contact

01/02/2019

01/05/2022

William Pao

Corporate Officer/Principal

01/05/2014

18/03/2022

Paul Bulcke

Director/Board Member	06/06/2011	01/01/2022
Independent Dir/Board Member	06/09/2011	15/03/2012

Gottlieb A. Keller

General Counsel	13/01/2010	31/03/2020
Corporate Secretary	01/01/2008	31/03/2020

John Bell

Director/Board Member	17/09/2009	17/03/2020
Independent Dir/Board Member	01/04/2011	12/09/2011
Corporate Officer/Principal	01/01/2001	17/09/2009

Andreas Oeri

Director/Board Member	13/01/2010	17/03/2020
Independent Dir/Board Member	06/09/2011	17/03/2020
Corporate Officer/Principal	01/01/1996	13/01/2010

Stephan Feldhaus

Public Communications Contact

08/09/2010

30/09/2019

Peter Voser

Director/Board Member	01/02/2011	30/06/2019
Independent Dir/Board Member	06/09/2011	15/03/2012

John Reed

Corporate Officer/Principal

02/04/2013

02/04/2018

Roland Diggelmann

Corporate Officer/Principal

01/01/2012

01/01/2018

Pius Baschera

Director/Board Member	13/01/2010	31/03/2017
Independent Dir/Board Member	06/09/2011	12/09/2011

DeAnne Shirley Julius

Director/Board Member	13/01/2010	01/03/2016
Independent Dir/Board Member	06/09/2011	01/03/2016
Corporate Officer/Principal	01/01/2002	13/01/2010

Beatrice Weder di Mauro

Director/Board Member	13/01/2010	01/03/2016
Independent Dir/Board Member	29/07/2011	12/09/2011

Silvia Ayyoubi

Human Resources Officer

13/01/2010

31/12/2015

Bernard Poussot

Director/Board Member	03/03/2015	-
Independent Dir/Board Member	03/03/2015	-

Hyam Levitsky

Corporate Officer/Principal

01/08/2011

01/02/2015

Michael Varney

Corporate Officer/Principal

01/01/2015

Richard Scheller

Corporate Officer/Principal

01/01/2009

31/12/2014

William Burns

Director/Board Member	01/03/2010	04/03/2014
Independent Dir/Board Member	01/03/2010	15/03/2012

Franz Humer

Chairman

06/09/2011

04/03/2014

Lodewijk J. R. de Vink

Director/Board Member	13/01/2010	05/03/2013
Independent Dir/Board Member	11/04/2011	12/09/2011
Corporate Officer/Principal	01/01/2004	13/01/2010

Bruno Gehrig

Director/Board Member	01/01/2004	05/03/2013
Independent Dir/Board Member	01/01/2004	15/03/2012

Jean-Jacques Garaud

Corporate Officer/Principal

01/01/2007

30/06/2012

Klaus Gustav Strein

Corporate Officer/Principal

14/09/2011

Erich Hunziker

Director/Board Member	18/01/2011	18/01/2011
Chief Tech/Sci/R&D Officer	13/01/2010	31/03/2011
Director of Finance/CFO	01/10/2001	31/03/2011

Wolfgang Ruttenstorfer

Director/Board Member	13/01/2010	14/12/2010
Independent Dir/Board Member	01/01/2007	01/01/2011

Walter Frey

Director/Board Member	13/01/2010	14/12/2010
Independent Dir/Board Member	01/01/2001	01/01/2011
Corporate Officer/Principal	01/01/2001	13/01/2010

David Goldstein

Corporate Officer/Principal

01/01/1994

01/01/2011

Peter Brabeck-Letmathe

Director/Board Member

01/03/2010

Arthur Levinson

Director/Board Member	01/03/2010	-
Independent Dir/Board Member	26/04/2011	12/09/2011

Eduard Enrico Holdener

Corporate Officer/Principal

01/01/1995

01/01/2007

Michael Burgess

Corporate Officer/Principal

24/10/2011

Rolf Hänggi

Director/Board Member

01/01/2006

Dirk W. Kirsten

Corporate Officer/Principal

01/01/2002

01/01/2004

Domenico Scala

Corporate Officer/Principal	01/01/1995	01/01/2000
Treasurer	01/01/2000	01/01/2003

Henri-Paul Meier

Investor Relations Contact	09/09/2011	-
Public Communications Contact	15/03/2002	-

Horst Teltschik

Director/Board Member	13/01/2010	-
Corporate Officer/Principal	01/01/2002	13/01/2010

Anton Affentranger

Director of Finance/CFO

Jürg Witmer

Public Communications Contact

01/01/1978

Vincent Charlon

Corporate Officer/Principal

01/01/1990

01/01/1998

Rolf Schläpfer

Public Communications Contact

01/01/1997

Unni Hjelmaas

Corporate Officer/Principal

01/01/1997

Gerard Farmer

General Counsel

01/01/1989

Pierre Jaccoud

Corporate Secretary

01/01/1988

Marc Salzberg

Corporate Officer/Principal

Wing-Kai Chan

Corporate Officer/Principal

Peter Boyle

Investor Relations Contact

Markus Hosang

Corporate Officer/Principal

Daniel O'Day

Corporate Officer/Principal

Eva Losert

Public Communications Contact

Simon Roitt

Corporate Officer/Principal

Ivan Melezínek

Corporate Officer/Principal

Ashok Dhanrajgir

Corporate Officer/Principal

Melanie Wolf

Public Communications Contact

Kuno Sommer

Corporate Officer/Principal

Alexander Klauser

Public Communications Contact

08/09/2010

Ann Moravick

Corporate Officer/Principal

Peter Johann

Sales & Marketing

Karl Mahler

Investor Relations Contact	-	-
Public Communications Contact	-	-

Andreas Emmenegger

Corporate Officer/Principal

Dámaso Molero

Corporate Officer/Principal

Andreas Greuter

General Counsel

Urs Jaisli

Compliance Officer

31/01/2013

Jean-Pierre Obrecht

Corporate Officer/Principal

Tim George

Sales & Marketing

Ken A. Brameld

Corporate Officer/Principal

Alexander Zehnder

Corporate Officer/Principal

Stefan Ryser

Human Resources Officer

Robert Salcedo

Corporate Officer/Principal

Tom Edward Pike

Corporate Officer/Principal

George Abercrombie

Corporate Officer/Principal

Fritz Hoffmann-la Roche

Founder

Age distribution of managers

Parity Men Women

Male	16
Female	8

Of which Executive Committee

Male	5
Female	4

Of which Directors

Male	9
Female	1

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Employees

103,249

Sector

Pharmaceuticals

More about the company